Evidence map›Paper›PMID 35449415›Full record

ArticleNature biotechnology2022

DestVI identifies continuums of cell types in spatial transcriptomics data.

Romain Lopez, Baoguo Li, Hadas Keren-Shaul, Pierre Boyeau, Merav Kedmi, David Pilzer, Adam Jelinski, Ido Yofe, Eyal David, Allon Wagner and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 164 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed, 1 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 1 synthesis or guideline pooled it, 226 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Romain Lopez *Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley CA, USA.ORCID http://orcid.org/0000-0003-0495-738X
Baoguo Li *Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Hadas Keren-Shaul *Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Pierre BoyeauDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley CA, USA.
Merav KedmiDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
David PilzerDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Adam JelinskiDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Ido YofeDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Eyal DavidDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Allon WagnerDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley CA, USA.
Can ErgenDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley CA, USA.
Yoseph AddadiDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-9827-0436
Ofra GolaniDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-9793-236X
Franca RoncheseMalaghan Institute of Medical Research, Wellington, New Zealand.ORCID http://orcid.org/0000-0001-5835-8230
Michael I JordanDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-8935-817X
Ido AmitDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel. ido.amit@weizmann.ac.il.ORCID http://orcid.org/0000-0003-2968-877X
Nir YosefDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley CA, USA. niryosef@berkeley.edu.ORCID http://orcid.org/0000-0001-9004-1225
Weizmann Institute of Science · ILUniversity of California, Berkeley · USMalaghan Institute of Medical Research · NZRagon Institute of MGH, MIT and Harvard · US

Funding

Tool and Technology Development CoreU19MH114821 · NIMH · COLD SPRING HARBOR LABORATORY · PI HUANG, Z JOSH · 2017 to 2021
$64.5M
Systems Biological Analysis of Innate and Adaptive Responses to VaccinationU19AI090023 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, LI, SHUZHAO · 2010 to 2021
$45.0M
Howard Hughes Medical InstituteNIAID NIH HHS U19 AI090023NIMH NIH HHS U19 MH114821
6 · The paper itself

Abstract

Most spatial transcriptomics technologies are limited by their resolution, with spot sizes larger than that of a single cell. Although joint analysis with single-cell RNA sequencing can alleviate this problem, current methods are limited to assessing discrete cell types, revealing the proportion of cell types inside each spot. To identify continuous variation of the transcriptome within cells of the same type, we developed Deconvolution of Spatial Transcriptomics profiles using Variational Inference (DestVI). Using simulations, we demonstrate that DestVI outperforms existing methods for estimating gene expression for every cell type inside every spot. Applied to a study of infected lymph nodes and of a mouse tumor model, DestVI provides high-resolution, accurate spatial characterization of the cellular organization of these tissues and identifies cell-type-specific changes in gene expression between different tissue regions or between conditions. DestVI is available as part of the open-source software package scvi-tools ( https://scvi-tools.org ).

Indexed as

NeoplasmsTranscriptomeAnimalsExome SequencingGene Expression ProfilingMiceSingle-Cell AnalysisSoftware

Identifiers

PMID35449415
PMCPMC9756396
OpenAlexW4224218779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.